RxSight
RXST----
RxSight (RXST)
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular len...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
RxSight Analyst Rating
View MoreForecast & Rating
Jul 15, 2026Price forecast
$8.4362.40%
Forecast & RatingHold
9analysts
- Strong buy0.00%
- Buy11.11%
- Hold66.67%
- Sell0.00%
- Strong sell22.22%
News
- PUBT · 1 day ago, 07:30 AM
AST SpaceMobile EVP and Chief of Staff Christopher E. Turco files initial beneficial ownership statement
- TradingView · Jul 15 at 03:33 PM
Aziz Mottiwala named President and CEO as Ron Kurtz becomes Chief Medical Officer at RxSight
- Market Beat · Jul 10 at 09:01 PM
RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook
- Tip Ranks · Jul 8 at 06:55 AM
Wells Fargo Sticks to Its Hold Rating for RxSight (RXST)
- Tip Ranks · Jul 7 at 04:25 AM
RxSight: Alcon Partnership and Margin Improvements Offset Near-Term Sales Shortfall; Buy Rating and $11 Price Target Reiterated
- benzinga_article · Jul 7 at 02:23 AM
Rivian Automotive, Penguin Solutions And 3 Stocks To Watch Heading Into Tuesday
